Also trades as: BLRX.TA (TLV) · $vol 0M
BLRX NASDAQ
BioLineRx Ltd.
1W: -8.8%
1M: -13.5%
3M: -25.0%
YTD: -15.4%
1Y: -38.8%
3Y: -97.1%
5Y: -98.0%
$2.37
+0.02 (+0.85%)
Weekly Expected Move ±6.1%
$2
$2
$2
$3
$3
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$1M
-95.9% ▼
Gross Profit
$430K
-97.8% ▼
Operating Income
-$10M
+49.2% ▲
Net Income
-$1M
+87.2% ▲
EPS (Diluted)
$-0.29
-150.6% ▼
EBITDA
-$10M
-351.2% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $5M | $29M | $1M |
| YoY Growth | +0.0% | +0.0% | +0.0% | +502.9% | -95.9% |
| Cost of Revenue | $0 | $0 | $4M | $9M | $759K |
| Gross Profit | $0 | $0 | $1M | $20M | $430K |
| Gross Margin | — | — | 23.1% | 68.0% | 36.2% |
| R&D Expenses | $19M | $18M | $13M | $9M | $8M |
| SG&A Expenses | $5M | $12M | $31M | $29M | $3M |
| Operating Expenses | $25M | $29M | $51M | $40M | $11M |
| Operating Income | -$25M | -$29M | -$50M | -$20M | -$10M |
| Operating Margin | — | — | -1035.3% | -70.5% | -871.8% |
| Interest Expense | $984K | $2M | $2M | $9M | $1M |
| Income Before Tax | -$27M | -$25M | -$61M | -$9M | -$2M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$27M | -$25M | -$61M | -$9M | -$1M |
| Net Margin | — | — | -1262.8% | -31.9% | -99.6% |
| EPS (Diluted) | $-0.61 | $-0.48 | $-0.94 | $-0.12 | $-0.29 |
| EBITDA | -$24M | -$29M | -$57M | $4M | -$10M |
| Shares Outstanding | 44M | 52M | 64M | 80M | 4M |